Ovarian cancer and the pelvic floor surgeon: The case for prophylactic bilateral salpingectomy during POP surgery

International Urogynecology Journal

Volumn 23, Issue 6, 2012, Pages 655-656

  Dwyer, Peter L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ANTINEOPLASTIC AGENT; TESTOSTERONE;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CLIMACTERIUM; EDITORIAL; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; MORTALITY; OVARIECTOMY; OVARY CANCER; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLACTIC BILATERAL SALPINGECTOMY; QUALITY OF LIFE; SALPINGECTOMY; SURGEON;

EID: 84865113647     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1727-x     Document Type: Editorial

References (9)

1. Piver MS (1996) Prophylactic oophorectomy: reducing the U.S. death rate from epithelial ovarian cancer. A continuing debate. Oncologist 1(5):326-330
2. Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E (2002) Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol 186(4):712-716 (Pubitemid 34494351)
3. Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ (2010) Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol 116(5):1088-1095
4. Brand A (2011) The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice? Aust N Z J Obstet Gynaecol 51(4):296-300
5. Olive DL (2005) Dogma, skepsis, and the analytic method; the role of prophylactic oophorectomy at the time of hysterectomy. Obstet Gynecol 106:214-215 (Pubitemid 41023255)
6. Shuster LT, Gostout BS, Grossard BD, Rocca WA (2008) Propylactic oophorectomy in pre-menopausal women and longterm health - a review. Menopause Int 14(3):111-116
7. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5(1):35-44 (Pubitemid 350218778)
8. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161-169 (Pubitemid 46175016)
9. Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407-1416